Colgate-Palmolive Balance Sheet Health
Financial Health criteria checks 4/6
Colgate-Palmolive has a total shareholder equity of $957.0M and total debt of $8.5B, which brings its debt-to-equity ratio to 887.8%. Its total assets and total liabilities are $16.4B and $15.4B respectively. Colgate-Palmolive's EBIT is $3.9B making its interest coverage ratio 17. It has cash and short-term investments of $1.1B.
Key information
887.8%
Debt to equity ratio
US$8.50b
Debt
Interest coverage ratio | 17x |
Cash | US$1.15b |
Equity | US$957.00m |
Total liabilities | US$15.44b |
Total assets | US$16.39b |
Recent financial health updates
Is Colgate-Palmolive (NYSE:CL) A Risky Investment?
Jan 19Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Oct 02Here's Why Colgate-Palmolive (NYSE:CL) Can Manage Its Debt Responsibly
Jun 05Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Feb 23Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Nov 16Recent updates
Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 18Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?
Feb 14Colgate-Palmolive: I'm Buying Before Interest Rates Decrease
Feb 14Colgate-Palmolive: Brushing Up Profits In Q4 2023
Jan 30Is Colgate-Palmolive (NYSE:CL) A Risky Investment?
Jan 19Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult
Jan 01Colgate-Palmolive: A Better Year Ahead (Rating Upgrade)
Dec 20Colgate-Palmolive Stock And Its Real Value
Nov 29Brush Up With Colgate-Palmolive Stock As Earnings Growth Drips On
Nov 14Colgate-Palmolive (NYSE:CL) Will Want To Turn Around Its Return Trends
Nov 06Colgate-Palmolive: Own This Dividend King At The Right Price
Oct 31Why Colgate-Palmolive Is A Bargain You Shouldn't Ignore Right Now
Oct 13Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Oct 02Colgate-Palmolive: Dividend King With Limited Growth
Sep 27An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 34% Undervalued
Sep 11Colgate-Palmolive: Improving Prospects And A Reasonable Valuation
Sep 09Colgate-Palmolive: A Healthy 7% Return With A Safe Dividend For Investors In A Post-Pandemic World
Aug 16Colgate And The Importance Of Sales Growth, Expectations Matter
Aug 09Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business
Aug 03Colgate-Palmolive: Challenging Growth Prospects
Jul 10Colgate-Palmolive (NYSE:CL) Is Increasing Its Dividend To $0.48
Jun 27Colgate-Palmolive (NYSE:CL) Will Pay A Larger Dividend Than Last Year At $0.48
Jun 13Colgate-Palmolive: The Reasons We Are Becoming More Cautious
Jun 05Here's Why Colgate-Palmolive (NYSE:CL) Can Manage Its Debt Responsibly
Jun 05Calculating The Intrinsic Value Of Colgate-Palmolive Company (NYSE:CL)
May 18Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Feb 23Calculating The Fair Value Of Colgate-Palmolive Company (NYSE:CL)
Feb 05What to expect from Colgate-Palmolive's Q4 2022 Earnings
Jan 26Colgate-Palmolive declares $0.47 dividend
Jan 12Lorrie Norrington named lead independent director of Colgate
Jan 03Colgate-Palmolive (NYSE:CL) Will Be Hoping To Turn Its Returns On Capital Around
Jan 01Colgate-Palmolive: I Like The Toothpaste But Not The Stock
Dec 22Colgate-Palmolive: Good Long-Term Prospects But Fairly Valued
Dec 07Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Nov 16Colgate-Palmolive Q3 2022 Earnings Preview
Oct 27Colgate gains on report activist Third Point takes stake
Oct 18Is Colgate-Palmolive Company (NYSE:CL) Trading At A 45% Discount?
Oct 11Colgate-Palmolive: 'Boring' Remains Attractive In The Current Market Environment
Sep 29Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business
Sep 23Colgate-Palmolive declares $0.47 dividend
Sep 09CP India names Prabha Narasimhan as MD, CEO
Sep 01Colgate-Palmolive: What Recent Results Mean For Long-Term Holders
Aug 25The New 1% Excise Tax On Stock Repurchases Could Impact Companies Such As Colgate- Palmolive
Aug 07Financial Position Analysis
Short Term Liabilities: CL's short term assets ($5.3B) exceed its short term liabilities ($4.7B).
Long Term Liabilities: CL's short term assets ($5.3B) do not cover its long term liabilities ($10.7B).
Debt to Equity History and Analysis
Debt Level: CL's net debt to equity ratio (768.1%) is considered high.
Reducing Debt: CL's debt to equity ratio has reduced from 3236% to 887.8% over the past 5 years.
Debt Coverage: CL's debt is well covered by operating cash flow (44.1%).
Interest Coverage: CL's interest payments on its debt are well covered by EBIT (17x coverage).